Newsmax shares soared for a second day after their public debut, as the conservative news channel gains traction during President Donald Trump’s second term.
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea
...
Read moreDetails

